Czechia· CZ-0238552
AMBRISENTAN VIATRIS
A ambrisentan product containing ambrisentan, registered in Czechia by VIATRIS LIMITED, Dublin. The same ATC class is registered in 18 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Ambrisentan is registered in 18 of 19 countries.
Countries holding a registration under ATC C02KX02 (ambrisentan), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 10 of them publish a price we can compare per daily dose
Ambrisentan · ATC C02KX02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ambrisentan costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ambrisentan · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$54.19
The record
At a glance
SÚKL (Czech Republic)- Active substance
- AMBRISENTAN
- Manufacturer
- VIATRIS LIMITED, Dublin
- Country
- Czechia (CZ)
- ATC code
- C02KX02
- ATC class
- Ambrisentan
- Defined daily dose
- 7.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
155 interactions on record for ambrisentan.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ambrisentan · interactions on record
155 records
- 5 severe
- 71 moderate
- 12 minor
- 67 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- CiclosporinL04AD01severe
- LeflunomideL04AK01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ambrisentan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesambrisentanAurobindo Pharma Limited
- SpainAMBRISENTAN ACCORD 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- NetherlandsAmbrisentan Accord 10 mg, filmomhulde tablettenAccord Healthcare B.V.
- FinlandAmbrisentan AccordAccord Healthcare B.V.
- FranceAMBRISENTAN ACCORD 10 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- SwedenAmbrisentan Accord 10 mg Filmdragerad tablettAccord Healthcare B.V.
- BelgiumAmbrisentan AB 10 mgAurobindo
- ItalyAMBRISENTAN MEDACMEDAC PHARMA S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Ambrisentan Accord, Ambrisentan Aop
- Belgium · Ambrisentan Accord, Ambrisentan Sandoz
- Bulgaria · Aмбрисентан Aкорд, Амбрисентан Зентива
- Cyprus · Ambrisentan Msn, Ambrisentan Sapiens
- Germany · Ambripuren, Ambrisentan
- Denmark · Ambrisentan "sandoz", Ambrisentan Accord
- Estonia · Ambrisentan Inteli, Ambrisentan Norameda
- Spain · Ambrisentan Accord, Ambrisentán Aurovitas
- Finland · Ambrisentan Accord
- France · Ambrisentan Accord, Ambrisentan Arrow
- United Kingdom (Northern Ireland) · Ambrisentan Accord, Ambrisentan Axunio
- Greece · Ambicipen, Ambrisentan Accord
- Croatia · Ambrisentan Accord
- Hungary · Ambrisentan Azr
- Ireland · Ambrisentan Accord
- Iceland · Ambrisentan Viatris, Volibris
- Italy · Ambrisentan Accord, Ambrisentan Medac
- Liechtenstein · Ambrisentan Viatris, Volibris
- Lithuania · Ambrisentan Aop, Ambrisentan Inteli
- Latvia · Ambrisentan Inteli, Ambrisentan Norameda
- Netherlands · Ambrisentan Accord, Ambrisentan Aop
- Norway · Ambrisentan Accord, Ambrisentan Viatris
- Portugal · Ambrisentano Accord, Ambrisentano Generis
- Sweden · Ambrisentan Accord, Ambrisentan Bluefish
- Slovenia · Ambrisentan Accord
- Slovakia · Ambrisentan Aop
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8d75c9d-f976-4f97-8a2c-8cf4f3e00ea4 GET /v1/drugs/f8d75c9d-f976-4f97-8a2c-8cf4f3e00ea4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "10MG",
"pack_size": "30",
"substance": "AMBRISENTAN",
"cz_kod_sukl": "0238552",
"product_type": "CH",
"substance_codes": "16475",
"registration_state": "R",
"registration_number": "EU/1/19/1368/003"
}See everything about ambrisentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.